This announcement is a separate document:
上海市通力律师事务所关于微芯生物2021年限制性股票激励计划第二个归属期符合归属条件、2021年股票增值权激励计划第二个行权期符合行权条件及作废部分相关限制性股票或股票增值权相关事项之法律意见书
Legal opinion of Shanghai Tongli Law Firm on matters relating to the second vesting period of the Microchip Biotech 2021 Restricted Stock Incentive Plan, the second exercise period of the 2021 Stock Value-added Incentive Plan, and the abolition of certain
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.